With the onset of influenza season and the potential overlap of influenza and COVID-19 symptoms, there is a need to be able to quickly differentiate between the two viruses to ensure that patients are appropriately managed. Category: UncategorizedBy CarDio-AdMin24/11/2020Leave a comment Author: CarDio-AdMin Post navigationPreviousPrevious post:First SGLT1/2 Inhibitor Shows ‘Spectacular’ Phase 3 Safety and Efficacy in T2DNextNext post:Metformin Improves Most Outcomes for T2D During PregnancyRelated PostsFDA Approves Tirzepatide for Treating Obesity28/01/2024Medical cannabis and the cardiovascular system: a dangerous combination?28/01/2024Air pollution and antibiotic resistance28/01/2024Air pollution and antibiotic resistance: is there cause for concern?05/11/2023Variation in gut microbiome a possible marker for colorectal cancer, study finds05/11/2023Is heart failure risk increased following COVID-19 infection?05/11/2023
